newsEMA recommends eight drugs for approval from April meeting5 May 2020 | By Victoria Rees (European Pharmaceutical Review)The EMA's human medicines committee has adopted a positive opinion for eight medicines, recommending their marketing authorisation.
newsDecision upheld in Merck hepatitis C drugs patent case5 November 2019 | By Rachael Harper (European Pharmaceutical Review)A US appeals court has upheld a ruling that threw out a $2.54 billion jury verdict Merck won against Gilead over hepatitis C treatments.